Isthmus Partners, LLC Haemonetics Corp Transaction History
Isthmus Partners, LLC
- $858 Million
- Q1 2024
A detailed history of Isthmus Partners, LLC transactions in Haemonetics Corp stock. As of the latest transaction made, Isthmus Partners, LLC holds 48,038 shares of HAE stock, worth $4.05 Million. This represents 0.48% of its overall portfolio holdings.
Number of Shares
48,038
Previous 17,888
168.55%
Holding current value
$4.05 Million
Previous $1.53 Million
168.15%
% of portfolio
0.48%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding HAE
# of Institutions
311Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Capital Research Global Investors Los Angeles, CA6.67MShares$562 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.98MShares$504 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$455 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$360 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$319 Million0.27% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.32B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...